Is UnitedHealth Group (UNH) a risky stock?
As of July 21, 2026, Clavix grades UnitedHealth Group (UNH) B+ for risk, a composite score of 73 out of 100 on an A+ to F scale, which puts UNH in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind UNH's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how UNH scores on each, as of July 21, 2026.
What's moving UNH's risk right now
Company-specific signals Clavix flags behind UNH's current grade, drawn from recent news and filings as of July 21, 2026.
UnitedHealth lost its defamation suit against The Guardian and is asking a Florida court to halt a malicious prosecution case, aiming to avoid costly discovery that could expose internal documents.
Growing medical cost trends in UnitedHealth's commercial insurance business could squeeze near-term profits, even as the stock still appears on positive screener lists like MarketBeat's top medical picks.
What a B+ grade means
On the Clavix A+ to F scale, UNH's composite of 73 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell UNH or any security. Grades are risk indicators, not predictions of return. Data may be delayed.